149 related articles for article (PubMed ID: 12727815)
1. CDKN1A and CDKN1B polymorphisms and risk of advanced prostate carcinoma.
Kibel AS; Suarez BK; Belani J; Oh J; Webster R; Brophy-Ebbers M; Guo C; Catalona WJ; Picus J; Goodfellow PJ
Cancer Res; 2003 May; 63(9):2033-6. PubMed ID: 12727815
[TBL] [Abstract][Full Text] [Related]
2. Variant genotypes of CDKN1A and CDKN1B are associated with an increased risk of breast cancer in Chinese women.
Ma H; Jin G; Hu Z; Zhai X; Chen W; Wang S; Wang X; Qin J; Gao J; Liu J; Wang X; Wei Q; Shen H
Int J Cancer; 2006 Nov; 119(9):2173-8. PubMed ID: 16804901
[TBL] [Abstract][Full Text] [Related]
3. A polymorphism in the CDKN1B gene is associated with increased risk of hereditary prostate cancer.
Chang BL; Zheng SL; Isaacs SD; Wiley KE; Turner A; Li G; Walsh PC; Meyers DA; Isaacs WB; Xu J
Cancer Res; 2004 Mar; 64(6):1997-9. PubMed ID: 15026335
[TBL] [Abstract][Full Text] [Related]
4. [Association of polymorphisms of p21cip1 and p27kip1 genes with susceptibilities of esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].
Guo W; Cui YJ; Fang SM; Li Y; Wang N; Zhang JH
Ai Zheng; 2006 Feb; 25(2):194-9. PubMed ID: 16480585
[TBL] [Abstract][Full Text] [Related]
5. CDKN1B Val 109 Gly variant is not related to risk of prostate cancer.
Zhu L; Wang J; Yue C; Yuan W; Zhang W; Shi L; Mi Y; Wu X; Zhang LF; Zuo L
J Cell Biochem; 2019 Oct; 120(10):18346-18356. PubMed ID: 31257659
[TBL] [Abstract][Full Text] [Related]
6. Genetic variants of p21 and p27 and pancreatic cancer risk in non-Hispanic Whites: a case-control study.
Chen J; Amos CI; Merriman KW; Wei Q; Sen S; Killary AM; Frazier ML
Pancreas; 2010 Jan; 39(1):1-4. PubMed ID: 19910837
[TBL] [Abstract][Full Text] [Related]
7. Genetic variants of p21 and p27 and hepatocellular cancer risk in a Chinese Han population: a case-control study.
Liu F; Wei YG; Luo LM; Wang WT; Yan LN; Wen TF; Xu MQ; Yang JY; Li B
Int J Cancer; 2013 May; 132(9):2056-64. PubMed ID: 23034899
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms of cell cycle control genes influence the development of sporadic medullary thyroid carcinoma.
Barbieri RB; Bufalo NE; Secolin R; Assumpção LV; Maciel RM; Cerutti JM; Ward LS
Eur J Endocrinol; 2014 Dec; 171(6):761-7. PubMed ID: 25565272
[TBL] [Abstract][Full Text] [Related]
9. Interaction effect of PTEN and CDKN1B chromosomal regions on prostate cancer linkage.
Xu J; Langefeld CD; Zheng SL; Gillanders EM; Chang BL; Isaacs SD; Williams AH; Wiley KE; Dimitrov L; Meyers DA; Walsh PC; Trent JM; Isaacs WB
Hum Genet; 2004 Aug; 115(3):255-62. PubMed ID: 15185141
[TBL] [Abstract][Full Text] [Related]
10. Association of genetic polymorphisms in cell-cycle control genes and susceptibility to endometrial cancer among Chinese women.
Cai H; Xiang YB; Qu S; Long J; Cai Q; Gao J; Zheng W; Shu XO
Am J Epidemiol; 2011 Jun; 173(11):1263-71. PubMed ID: 21454826
[TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphisms of p21 are associated with risk of squamous cell carcinoma of the head and neck.
Li G; Liu Z; Sturgis EM; Shi Q; Chamberlain RM; Spitz MR; Wei Q
Carcinogenesis; 2005 Sep; 26(9):1596-602. PubMed ID: 15878916
[TBL] [Abstract][Full Text] [Related]
12. CDKN1A (p21 gene) polymorphisms correlates with age in esophageal cancer.
Kaya Z; Karan BM; Almalı N
Mol Biol Rep; 2022 Jan; 49(1):249-258. PubMed ID: 34743275
[TBL] [Abstract][Full Text] [Related]
13. Association of p53 and p21(CDKN1A/WAF1/CIP1) polymorphisms with oral cancer in Taiwan patients.
Bau DT; Tsai MH; Lo YL; Hsu CM; Tsai Y; Lee CC; Tsai FJ
Anticancer Res; 2007; 27(3B):1559-64. PubMed ID: 17595776
[TBL] [Abstract][Full Text] [Related]
14. Association of CDKN1B gene polymorphisms with susceptibility to breast cancer: a meta-analysis.
Xiang H; Li H; Ge W; Wu W; Gao M; Wang W; Hong L; Jiang D; Zhang C
Mol Biol Rep; 2013 Nov; 40(11):6371-7. PubMed ID: 24078094
[TBL] [Abstract][Full Text] [Related]
15. Association between CDKN1A gene rs1801270 polymorphisms and susceptibility to colorectal cancser in an Iranian population.
Zali N; Savabkar S; Tajali R; Chaleshi V; Nazemalhosseini Mojarad E; Vahedi M; Hashemi M; Asadzadeh Aghdaei H
Nucleosides Nucleotides Nucleic Acids; 2023; 42(7):563-570. PubMed ID: 36691945
[No Abstract] [Full Text] [Related]
16. The functional variant rs34330 of CDKN1B is associated with risk of neuroblastoma.
Capasso M; McDaniel LD; Cimmino F; Cirino A; Formicola D; Russell MR; Raman P; Cole KA; Diskin SJ
J Cell Mol Med; 2017 Dec; 21(12):3224-3230. PubMed ID: 28667701
[TBL] [Abstract][Full Text] [Related]
17. Contribution of Cyclin-dependent Kinase Inhibitor 1B Genotypes to Childhood Leukemia Risk.
Pei JS; Chang WS; Hsu PC; Chen CC; Yang YC; Hsu SW; Hsu YN; Wang YC; Wang CH; Tsai CW; Bau DT
In Vivo; 2022; 36(4):1637-1642. PubMed ID: 35738638
[TBL] [Abstract][Full Text] [Related]
18. Role of DNA repair and cell cycle control genes in ovarian cancer susceptibility.
Mohamed FZ; Hussien YM; AlBakry MM; Mohamed RH; Said NM
Mol Biol Rep; 2013 May; 40(5):3757-68. PubMed ID: 23277402
[TBL] [Abstract][Full Text] [Related]
19. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features.
Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ
Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796
[TBL] [Abstract][Full Text] [Related]
20. Association between CDKN1A Ser31Arg and C20T gene polymorphisms and colorectal cancer risk and prognosis.
Cacina C; Yaylim-Eraltan I; Arikan S; Saglam EK; Zeybek U; Isbir T
In Vivo; 2010; 24(2):179-83. PubMed ID: 20363991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
